Priyadarshini Mamindla

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers”.

Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001752

N/A

0DataRank · unranked

54 citations

Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey +13 more

Author response to Cunha et al

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003299

N/A

0DataRank · unranked

5 citations

Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey +13 more

Evaluation of radiomics as a predictor of tumor hypoxia and response to anti-PD-1 mab treatment (IO) in recurrent/metastatic HNSCC patients (R/M).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.6045

N/A

0DataRank · unranked

1 citations

Şerafettin Zenkin, Murat Ak, Priyadarshini Mamindla, Vishal Peddagangireddy, Ashley V. Menk +7 more

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02379-1

N/A

0DataRank · unranked

109 citations

Alessandro Russo, Óscar Arrieta, Murat Ak, Feliciano Barrón, Muthukumar Gunasekaran +20 more

Evaluation of radiomics as a predictor of efficacy and the tumor immune microenvironment in anti‐PD‐1 mAb treated recurrent/metastatic squamous cell carcinoma of the head and neck patients

Head & Neck(2024)10.1002/hed.27878

N/A

0DataRank · unranked

5 citations

Şerafettin Zenkin, Murat Ak, Priyadarshini Mamindla, Vishal Peddagangireddy, Ronan W. Hsieh +8 more

Radiomic analysis of patient and interorgan heterogeneity in response to immunotherapies and BRAF-targeted therapy in metastatic melanoma

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009568

N/A

0DataRank · unranked

7 citations

Zane Gray, Rebekah Dadey, Şerafettin Zenkin, Nasim Batavani, Sarah Newman +19 more